BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:32 PM
 | 
Jul 30, 2007
 |  BC Extra  |  Politics & Policy

CMS releases final NCD for ESA coverage

The Centers for Medicare and Medicaid Services released final guidance for its National Coverage Decision (NCD) on erythropoiesis-stimulating agents (ESA) for cancer and related neoplastic conditions. Effective Monday, the required hemoglobin level for ESA initiation is below 10 g/dL (or the hematocrit level less than 30%). The original proposal would have limited ESAs for cancer...

Read the full 253 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >